EVEON signed an agreement with the pharmaceutical group Advanced Accelerator Applications for a medical injection device in oncology.
EVEON's objective is to develop and produce an innovative automated injection system for the treatment of solid tumours.

EVEON was awarded, in december 2014, the 1st prize Monday evening in the Inventer Demain (Invent Tomorrow) international competition after winning the vote of an expert jury and the audience.

EVEON and CEA-Leti announced, in April 2004, the demonstration of liquid-pumping for smart drug delivery in the bolus mode using a silicon-based micro-pump fabricated with a standard MEMS process.